MA27416A1 - Cellules pulmonaires du rat des cotonniers pour la culture de virus - Google Patents

Cellules pulmonaires du rat des cotonniers pour la culture de virus

Info

Publication number
MA27416A1
MA27416A1 MA27878A MA27878A MA27416A1 MA 27416 A1 MA27416 A1 MA 27416A1 MA 27878 A MA27878 A MA 27878A MA 27878 A MA27878 A MA 27878A MA 27416 A1 MA27416 A1 MA 27416A1
Authority
MA
Morocco
Prior art keywords
cotton rat
virus culture
pulmonary cells
cells
pathogens
Prior art date
Application number
MA27878A
Other languages
English (en)
French (fr)
Inventor
Frederic R David
Michael E Tanner
Sudhir K Reddy
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MA27416A1 publication Critical patent/MA27416A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA27878A 2002-03-20 2004-09-28 Cellules pulmonaires du rat des cotonniers pour la culture de virus MA27416A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36601402P 2002-03-20 2002-03-20
US10/391,498 US7906311B2 (en) 2002-03-20 2003-03-18 Cotton rat lung cells for virus culture

Publications (1)

Publication Number Publication Date
MA27416A1 true MA27416A1 (fr) 2005-07-01

Family

ID=29553339

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27878A MA27416A1 (fr) 2002-03-20 2004-09-28 Cellules pulmonaires du rat des cotonniers pour la culture de virus

Country Status (16)

Country Link
US (1) US7906311B2 (de)
EP (1) EP1517987B1 (de)
KR (1) KR20050005426A (de)
CN (1) CN1653172A (de)
AT (1) ATE511397T1 (de)
AU (1) AU2003265230B8 (de)
BR (1) BRPI0308736B1 (de)
CA (1) CA2479747C (de)
CY (1) CY1111775T1 (de)
DK (1) DK1517987T3 (de)
MA (1) MA27416A1 (de)
MX (1) MXPA04009050A (de)
PT (1) PT1517987E (de)
RU (1) RU2376370C2 (de)
SI (1) SI1517987T1 (de)
WO (1) WO2003102021A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
MX2009007457A (es) 2007-01-12 2009-08-12 Univ Illinois Celulas que no son de mono para el desarrollo del virus del sindrome porcino reproductor y respiratorio (prrs).
RU2496870C2 (ru) * 2011-02-15 2013-10-27 Государственное научное учреждение Прикаспийский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук Способ получения эпителиоподобных клеток легкого плода буйволицы для культивирования вирусов
CN103893750B (zh) * 2012-12-31 2015-11-25 普莱柯生物工程股份有限公司 一种抗猪伪狂犬病、猪流感疫苗组合物及其应用
JP6328750B2 (ja) 2013-06-05 2018-05-23 エルジー エレクトロニクス インコーポレイティド 無線通信システムにおいてチャネル状態情報送信方法及び装置
CN103387604B (zh) * 2013-07-25 2015-04-15 中国农业科学院上海兽医研究所 鸡ibv s1蛋白的cd8+t细胞抗原表位多肽
CN112316129B (zh) 2014-04-03 2025-01-28 勃林格殷格翰动物保健美国有限公司 猪流行性腹泻病毒疫苗
CN108130316A (zh) * 2018-02-09 2018-06-08 天康生物股份有限公司 猪流行性腹泻病毒及其分离方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408437A (en) 1972-10-16 1975-10-01 C Vet Ltd Vaccines
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
FR2693472B1 (fr) 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
US5616326A (en) 1990-01-25 1997-04-01 The University Court Of The University Of Glasgow Recombinant canine adenovirus 2 (CAV-2)
CA2290906C (en) 1991-06-06 2003-04-01 Stichting Centraal Diergeneeskundig Instituut Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
KR0138092B1 (ko) * 1991-08-26 1998-04-30 제임스 씨. 데세사레 미확인(Mystery) 돼지 질병 관련 바이러스제
KR100241221B1 (ko) 1991-08-26 2000-03-02 에드워드 콜린스 제임스 돼지 불임 및 호흡기계 중후백신 및 그의 진단법
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
JP2521226B2 (ja) 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
NZ261992A (en) 1993-02-08 1996-06-25 Bayer Ag Porcine reproductive and respiratory syndrome virus, cultures, attenuated forms and vaccines thereof
ES2165405T3 (es) 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
EP0732340B1 (de) 1995-03-14 2004-06-09 Akzo Nobel N.V. Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
DE69633233T2 (de) * 1995-06-12 2005-08-11 Kansas State University Research Foundation, Manhattan Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
FR2750865B1 (fr) 1996-06-27 1998-12-04 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
US5976537A (en) 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
US6090393A (en) 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
JP2950273B2 (ja) 1997-01-27 1999-09-20 株式会社微生物化学研究所 ウシロタウイルス病ワクチン
US6368603B1 (en) 1997-03-05 2002-04-09 Merial Limited Lyme combination compositions and uses
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6492343B1 (en) * 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
EP1100925B1 (de) 1998-07-31 2006-01-18 Akzo Nobel N.V. Attenuierte pferdeherpesvirus
US20020037274A1 (en) * 1998-10-26 2002-03-28 Angelica Williams Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
NZ501264A (en) 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6379676B2 (en) 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
CA2365911A1 (en) 1999-04-09 2000-10-19 Schering-Plough Ltd. Recombinant and mutant adenoviruses derived of bovine adenovirus type 1
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1129722A1 (de) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
CA2413265A1 (en) 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
BR0111366A (pt) 2000-05-24 2003-05-20 Merial Sas Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
EP1383918A4 (de) * 2001-04-03 2005-01-05 Biosynexus Inc Tiermodell für darmpathogene

Also Published As

Publication number Publication date
US20030219460A1 (en) 2003-11-27
HK1070671A1 (en) 2005-06-24
PT1517987E (pt) 2011-07-12
DK1517987T3 (da) 2011-07-11
AU2003265230B2 (en) 2009-02-19
EP1517987B1 (de) 2011-06-01
EP1517987A4 (de) 2006-12-20
ATE511397T1 (de) 2011-06-15
RU2376370C2 (ru) 2009-12-20
CN1653172A (zh) 2005-08-10
CA2479747C (en) 2010-10-19
WO2003102021A3 (en) 2004-09-30
EP1517987A2 (de) 2005-03-30
BR0308736A (pt) 2005-08-16
CA2479747A1 (en) 2003-12-11
RU2004130864A (ru) 2005-05-10
AU2003265230A1 (en) 2003-12-19
US7906311B2 (en) 2011-03-15
MXPA04009050A (es) 2005-06-08
KR20050005426A (ko) 2005-01-13
WO2003102021A2 (en) 2003-12-11
SI1517987T1 (sl) 2011-09-30
BRPI0308736B1 (pt) 2016-04-05
AU2003265230B8 (en) 2009-06-18
CY1111775T1 (el) 2015-10-07

Similar Documents

Publication Publication Date Title
CY1111775T1 (el) Πνευμονικα κυτταρα βαμβακοαρουραιου για καλλιεργεια ιου
MY146518A (en) Methods to culture circovirus.
SG171577A1 (en) Methods for producing yeast-based vaccines
CY1114598T1 (el) Μεθοδος για την ενισχυση ενος ιου φυσαλιδωδους νοσου υπο συνθηκες ελευθερες ορου
ATE466932T1 (de) Vermehrung von viren in zellkultur
WO2006070370A3 (en) Stem cells culture systems
SE0201328D0 (sv) Hematopoietic differentiation of human embryonic stem cells
DK0904351T3 (da) Dyreceller og fremgangsmåder til replikationen af influenzavirus
DK1428878T3 (da) Fremgangsmåde til produktion og oprensning af erythropoietin
EP1831353A4 (de) Nichttumorbildende mdck-zellinie zur vermehrung von viren
RU2009130630A (ru) Способ получения мезенхимной клетки, способ получения зуба и мезенхимная клетка для формирования зуба
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
RU2007148138A (ru) Способ формирования зуба, зубной ряд и способ формирования ткани
WO2003067213A3 (en) Modulation of sulfate permease for photosynthetic hydrogen production
EP1155114A4 (de) Pluripotente embryonale keimzellinie aus vögeln
UA92157C2 (ru) Способ продуцирования гормона роста
DK1720979T3 (da) Anvendelse af et serumfrit celledyrkningsmedium til fremstilling af IL-18BP I pattedyrceller
EP1619245A4 (de) Verfahren zur herstellung von knorpelzellen zur transplantation
DK1343369T3 (da) Konservering af celler
ATE473437T1 (de) In situ wachsenlassen, einfrieren und testen von kultivierten zellen
CA2624544A1 (en) Vero cell line adapted to grow in suspension
AU2001278700A1 (en) Method of culturing human chondrocytes
DE60023006D1 (de) Neues verfahren zur herstellung und auswahl von transgenen flachspflanzen und leinsamen
WO2003100010A3 (en) Cytokine-free growth and maintenance of progenitor cells
ATE469209T1 (de) Herstellung und verwendung von basalmembranpartikeln